VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 3 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $68 | -62.2% | 7,231 | -1.5% | 0.00% | -57.1% |
| Q2 2023 | $180 | +4.7% | 7,344 | -0.6% | 0.01% | 0.0% |
| Q1 2023 | $172 | -8.5% | 7,386 | -0.4% | 0.01% | -12.5% |
| Q4 2022 | $188 | -99.9% | 7,412 | -16.9% | 0.01% | +14.3% |
| Q3 2022 | $172,000 | -40.1% | 8,917 | -20.8% | 0.01% | -12.5% |
| Q2 2022 | $287,000 | +282.7% | 11,253 | +283.7% | 0.01% | +300.0% |
| Q1 2022 | $75,000 | -46.8% | 2,933 | -12.8% | 0.00% | -33.3% |
| Q4 2021 | $141,000 | -2.8% | 3,362 | +0.8% | 0.00% | 0.0% |
| Q3 2021 | $145,000 | -11.0% | 3,336 | -3.5% | 0.00% | 0.0% |
| Q2 2021 | $163,000 | – | 3,456 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $14,609,161 | 17.42% |
| SB INVESTMENT ADVISERS (UK) LTD | 16,684,041 | $156,329,464 | 1.29% |
| Octagon Capital Advisors LP | 325,050 | $3,045,719 | 0.47% |
| SECTOR GAMMA AS | 148,538 | $1,391,801 | 0.36% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 1,345,635 | $12,608,600 | 0.31% |
| ALGERT GLOBAL LLC | 449,685 | $4,214 | 0.20% |
| Quantamental Technologies LLC | 18,519 | $173,523 | 0.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 47,000 | $439,920 | 0.15% |
| DUALITY ADVISERS, LP | 123,871 | $1,160,671 | 0.14% |
| Empowered Funds, LLC | 385,135 | $3,608,715 | 0.11% |